Dr. Lowentritt is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
6535 N Charles St
Ste 625
Baltimore, MD 21204Phone+1 410-825-5454Fax+1 410-825-5811- Is this information wrong?
Education & Training
- University of MarylandResidency, Urology, 2001 - 2005
- University of MarylandResidency, Surgery, 1999 - 2001
- Baylor College of MedicineClass of 1999
Certifications & Licensure
- MD State Medical License 2005 - 2024
- LA State Medical License 2005 - 2012
- American Board of Urology Urology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts Professional EHR, Allscripts, 2013
- Fellow (FACS) American College of Surgeons
Publications & Presentations
PubMed
- Evaluating relugolix for the treatment of prostate cancer in real-world settings of care: the OPTYX study protocol.Daniel E Spratt, Tanya Dorff, Rana R McKay, Benjamin H Lowentritt, Mark Fallick, Sergio C Gatoulis, Scott C Flanders, Ashley E Ross> ;Future Oncology. 2024 Apr 1
- 1 citationsIncidence of Cardiovascular Events in Patients With Prostate Cancer and Treated With Androgen Deprivation Therapy.Benjamin Lowentritt, Mark Fallick, Janis Pruett, Tao Jiang, Eddie Li, Bruce Brown, Robert Dufour> ;Urology Practice. 2024 Jan 1
- Comparison of prostate-specific antigen response in patients with metastatic castration-sensitive prostate cancer initiated on apalutamide or abiraterone acetate: A re...Benjamin Lowentritt, Dominic Pilon, Dexter Waters, Carmine Rossi, Erik Muser, Siyana Kurteva, Aditi Shah, Ibrahim Khilfeh, Shawn Du, Lorie Ellis, Patrick Lefebvre, Gor...> ;Urologic Oncology. 2023 May 1
- Join now to see all
Press Mentions
- New ERLEADA® (Apalutamide) Analysis Demonstrates Rapid, Deep Prostate-Specific Antigen (PSA) Response in Patients with Metastatic Castration-Sensitive Prostate Cancer (mCSPC)February 14th, 2022
- (Apalutamide) Oral Presentations Demonstrate Importance of Prostate Specific Antigen (PSA) as Key Efficacy Indicator and Show Strong Patient Adherence RatesSeptember 12th, 2021
- The Latest on Prostate Cancer and Bone Health WebinarOctober 31st, 2018
Professional Memberships
- Member
Hospital Affiliations
- University of Maryland Baltimore Washington Medical CenterGlen Burnie, Maryland
- Greater Baltimore Medical CenterTowson, Maryland
- MedStar Union Memorial HospitalBaltimore, Maryland
- University of Maryland St. Joseph Medical CenterTowson, Maryland
- MedStar Franklin Square Medical CenterRosedale, Maryland
- Sinai Hospital of BaltimoreBaltimore, Maryland
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: